About mediford ( Mediford Corporation )

Corporate Profile

Company Name
Mediford Corporation
Head Office
36-1 Shimizu-cho, Itabashi-ku, Tokyo 174-0053
President and CEO
Kei Shimizu
Paid-in Capital
80 million yen (as of November 1, 2023)
Shareholder
PHC Holdings Corporation
Business
R&D Support Services for Pharmaceuticals, Medical Devices, Regenerative Medicinal Products, etc.
Number of Employees
600 (as of Nov 1, 2023)
Main Places of Business
HQ, Analytical Research Center, Kashima Laboratories, Kumamoto Laboratories

History

1977
Established Mitsubishi Kasei Safety Institute Inc.
1985
Established Panapharm Laboratories Co., Ltd.
1988
Established Mitsubishi Yuka Bio-Clinical Laboratories. Inc.
2007
Merged Mitsubishi Chemical Safety Institute Inc., Mitsubishi Kagaku Iatron Inc. and Mitsubishi Kagaku Bio-Clinical Laboratories, Inc., to launch Mitsubishi Chemical Medience Corporation (Later the name changed to LSI Medience Corporation)
2019
Parent company changed to PHCHD
2021
Demerged the non-clinical business from LSI Medience Corporation and started LSIM Safety Institute Corporation
2023.11
Succeeded the clinical trial business of LSI Medience Corporation to LSIM Safety Institute Corporation, then newly started as Mediford Corporation wholly owned subsidiary of PHCHD

Qualified Personnel

Veterinarians
26
Medical Doctor
(incl. licensed in overseas)
1
Pharmacists
26
Clinical laboratory technicians
(Medical Technologist)
50
Health supervisors
8
Health laboratory technicians
5